메뉴 건너뛰기




Volumn 52, Issue 2, 2011, Pages 79-89

Metabolomics: A novel approach to early and noninvasive prostate cancer detection

Author keywords

Biological markers; Detection; Metabolomics; Prostatic neoplasms

Indexed keywords

SARCOSINE;

EID: 79952502199     PISSN: 20056737     EISSN: 20056745     Source Type: Journal    
DOI: 10.4111/kju.2011.52.2.79     Document Type: Review
Times cited : (61)

References (100)
  • 3
    • 30444442520 scopus 로고    scopus 로고
    • Comparison of prostate cancer mortality in five countries: France, Italy, Japan, UK and USA from the WHO mortality database (1960-2000)
    • Marugame T, Mizuno S. Comparison of prostate cancer mortality in five countries: France, Italy, Japan, UK and USA from the WHO mortality database (1960-2000). Jpn J Clin Oncol 2005; 35:690-1.
    • (2005) Jpn J Clin Oncol , vol.35 , pp. 690-691
    • Marugame, T.1    Mizuno, S.2
  • 4
    • 16344368667 scopus 로고    scopus 로고
    • Changing demography of prostate cancer in Asia
    • DOI 10.1016/j.ejca.2004.12.033, Prostate Cancer: Progress in Molecular and Clinical Science
    • Sim HG, Cheng CW. Changing demography of prostate cancer in Asia. Eur J Cancer 2005;41:834-45. (Pubitemid 40467547)
    • (2005) European Journal of Cancer , vol.41 , Issue.6 , pp. 834-845
    • Sim, H.G.1    Cheng, C.W.S.2
  • 5
    • 74749094140 scopus 로고    scopus 로고
    • Putative molecular signatures for the imaging of prostate cancer
    • Yang SY, Adelstein J, Kassis AI. Putative molecular signatures for the imaging of prostate cancer. Expert Rev Mol Diagn 2010;10:65-74.
    • (2010) Expert Rev Mol Diagn , vol.10 , pp. 65-74
    • Yang, S.Y.1    Adelstein, J.2    Kassis, A.I.3
  • 6
    • 0036403266 scopus 로고    scopus 로고
    • Prostate cancer diagnosis, staging and survival
    • DOI 10.1023/A:1020104004588
    • Narain V, Cher ML, Wood DP Jr. Prostate cancer diagnosis, staging and survival. Cancer Metastasis Rev 2002;21:17-27. (Pubitemid 35205191)
    • (2002) Cancer and Metastasis Reviews , vol.21 , Issue.1 , pp. 17-27
    • Narain, V.1    Cher, M.L.2    Wood Jr., D.P.3
  • 7
    • 49049102974 scopus 로고    scopus 로고
    • Benefits and harms of prostate-specific antigen screening for prostate cancer: An evi dence update for the U.S. Preventive Services Task Force
    • Lin K, Lipsitz R, Miller T, Janakiraman S. Benefits and harms of prostate-specific antigen screening for prostate cancer: an evi dence update for the U.S. Preventive Services Task Force. Ann Intern Med 2008;149:192-9.
    • (2008) Ann Intern Med , vol.149 , pp. 192-199
    • Lin, K.1    Lipsitz, R.2    Miller, T.3    Janakiraman, S.4
  • 8
    • 17844377337 scopus 로고    scopus 로고
    • PSA testing: What is the use?
    • Crawford ED. PSA testing: what is the use? Lancet 2005;365: 1447-9.
    • (2005) Lancet , vol.365 , pp. 1447-1449
    • Crawford, E.D.1
  • 9
    • 2442715038 scopus 로고    scopus 로고
    • Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter
    • Thompson IM, Pauler DK, Goodman PJ, Tangen CM, Lucia MS, Parnes HL, et al. Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter. N Engl J Med 2004;350:2239-46.
    • (2004) N Engl J Med , vol.350 , pp. 2239-2246
    • Thompson, I.M.1    Pauler, D.K.2    Goodman, P.J.3    Tangen, C.M.4    Lucia, M.S.5    Parnes, H.L.6
  • 10
    • 64349085626 scopus 로고    scopus 로고
    • Critical appraisal of prostate-specific antigen in prostate cancer screening: 20 years later
    • Pienta KJ. Critical appraisal of prostate-specific antigen in prostate cancer screening: 20 years later. Urology 2009;73(5 Suppl): S11-20.
    • (2009) Urology , vol.73 , Issue.5 SUPPL.
    • Pienta, K.J.1
  • 12
    • 63249117669 scopus 로고    scopus 로고
    • Screening for prostate cancer- The controversy that refuses to die
    • Barry MJ. Screening for prostate cancer - the controversy that refuses to die. N Engl J Med 2009;360:1351-4.
    • (2009) N Engl J Med , vol.360 , pp. 1351-1354
    • Barry, M.J.1
  • 14
    • 0036792052 scopus 로고    scopus 로고
    • Impact of age on total and complexed prostate-specific antigen cutoffs in a contemporary referral series of men with prostate cancer
    • Veltri RW, Miller MC, O'dowd GJ, Partin AW. Impact of age on total and complexed prostate-specific antigen cutoffs in a contemporary referral series of men with prostate cancer. Urology 2002;60(4 Suppl 1):47-52.
    • (2002) Urology , vol.60 , Issue.4 SUPPL. 1 , pp. 47-52
    • Veltri, R.W.1    Miller, M.C.2    O'Dowd, G.J.3    Partin, A.W.4
  • 15
    • 33644824294 scopus 로고    scopus 로고
    • The natural history of benign prostatic hyperplasia
    • DOI 10.1111/j.1464-410X.2006.06097.x
    • Fitzpatrick JM. The natural history of benign prostatic hyperplasia. BJU Int 2006;97(Suppl 2):3-6. (Pubitemid 43356987)
    • (2006) BJU International , vol.97 , Issue.SUPPL. 2 , pp. 3-6
    • Fitzpatrick, J.M.1
  • 17
    • 34147116255 scopus 로고    scopus 로고
    • Early Prostate Cancer Antigen Expression in Predicting Presence of Prostate Cancer in Men with Histologically Negative Biopsies
    • DOI 10.1016/j.juro.2007.01.013, PII S0022534707000134
    • Hansel DE, DeMarzo AM, Platz EA, Jadallah S, Hicks J, Epstein JI, et al. Early prostate cancer antigen expression in predicting presence of prostate cancer in men with histologically negative biopsies. J Urol 2007;177:1736-40. (Pubitemid 46560651)
    • (2007) Journal of Urology , vol.177 , Issue.5 , pp. 1736-1740
    • Hansel, D.E.1    DeMarzo, A.M.2    Platz, E.A.3    Jadallah, S.4    Hicks, J.5    Epstein, J.I.6    Partin, A.W.7    Netto, G.J.8
  • 18
    • 42949103970 scopus 로고    scopus 로고
    • The metabolites citrate, myo-inositol, and spermine are potential age-independent markers of prostate cancer in human expressed prostatic secretions
    • DOI 10.1002/pros.20727
    • Serkova NJ, Gamito EJ, Jones RH, O'Donnell C, Brown JL, Green S, et al. The metabolites citrate, myo-inositol, and spermine are potential age-independent markers of prostate cancer in human expressed prostatic secretions. Prostate 2008;68:620-8. (Pubitemid 351614640)
    • (2008) Prostate , vol.68 , Issue.6 , pp. 620-628
    • Serkova, N.J.1    Gamito, E.J.2    Jones, R.H.3    O'Donnell, C.4    Brown, J.L.5    Green, S.6    Sullivan, H.7    Hedlund, T.8    Crawford, E.D.9
  • 19
    • 77956524969 scopus 로고    scopus 로고
    • Characterizing human cancer metabolomics with ex vivo 1H HRMAS MRS
    • DeFeo EM, Cheng LL. Characterizing human cancer metabolomics with ex vivo 1H HRMAS MRS. Technol Cancer Res Treat 2010;9:381-91.
    • (2010) Technol Cancer Res Treat , vol.9 , pp. 381-391
    • DeFeo, E.M.1    Cheng, L.L.2
  • 20
    • 34147215441 scopus 로고    scopus 로고
    • Imaging prostate cancer: A multidisciplinary perspective
    • DOI 10.1148/radiol.2431030580
    • Hricak H, Choyke PL, Eberhardt SC, Leibel SA, Scardino PT. Imaging prostate cancer: a multidisciplinary perspective. Radiology 2007;243:28-53. (Pubitemid 46579693)
    • (2007) Radiology , vol.243 , Issue.1 , pp. 28-53
    • Hricak, H.1    Choyke, P.L.2    Eberhardt, S.C.3    Leibel, S.A.4    Scardino, P.T.5
  • 22
    • 60149091657 scopus 로고    scopus 로고
    • Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression
    • Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, et al. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 2009;457:910-4.
    • (2009) Nature , vol.457 , pp. 910-914
    • Sreekumar, A.1    Poisson, L.M.2    Rajendiran, T.M.3    Khan, A.P.4    Cao, Q.5    Yu, J.6
  • 23
    • 0032694577 scopus 로고    scopus 로고
    • 'Metabonomics': Understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data
    • Nicholson JK, Lindon JC, Holmes E. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 1999;29:1181-9.
    • (1999) Xenobiotica , vol.29 , pp. 1181-1189
    • Nicholson, J.K.1    Lindon, J.C.2    Holmes, E.3
  • 24
    • 33745512125 scopus 로고    scopus 로고
    • The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: Connecting the dots
    • Costello LC, Franklin RB. The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: connecting the dots. Mol Cancer 2006;5:17.
    • (2006) Mol Cancer , vol.5 , pp. 17
    • Costello, L.C.1    Franklin, R.B.2
  • 25
    • 3042823722 scopus 로고    scopus 로고
    • Metabolic profiles of cancer cells
    • Griffin JL, Shockcor JP. Metabolic profiles of cancer cells. Nat Rev Cancer 2004;4:551-61. (Pubitemid 38868624)
    • (2004) Nature Reviews Cancer , vol.4 , Issue.7 , pp. 551-561
    • Griffin, J.L.1    Shockcor, J.P.2
  • 26
    • 60149111699 scopus 로고    scopus 로고
    • Diagnostics: The prostate-cancer metabolome
    • Abate-Shen C, Shen MM. Diagnostics: the prostate-cancer metabolome. Nature 2009;457:799-800.
    • (2009) Nature , vol.457 , pp. 799-800
    • Abate-Shen, C.1    Shen, M.M.2
  • 27
    • 59449097019 scopus 로고    scopus 로고
    • Clinical applications of metabolomics in oncology: A review
    • Spratlin JL, Serkova NJ, Eckhardt SG. Clinical applications of metabolomics in oncology: a review. Clin Cancer Res 2009;15: 431-40.
    • (2009) Clin Cancer Res , vol.15 , pp. 431-440
    • Spratlin, J.L.1    Serkova, N.J.2    Eckhardt, S.G.3
  • 29
    • 60349085340 scopus 로고    scopus 로고
    • Prostatic fluid electrolyte composition for the screening of prostate cancer: A potential solution to a major problem
    • Costello LC, Franklin RB. Prostatic fluid electrolyte composition for the screening of prostate cancer: a potential solution to a major problem. Prostate Cancer Prostatic Dis 2009;12:17-24.
    • (2009) Prostate Cancer Prostatic Dis , vol.12 , pp. 17-24
    • Costello, L.C.1    Franklin, R.B.2
  • 30
    • 79955965382 scopus 로고    scopus 로고
    • Metabolic signatures of malignant progression in prostate epithelial cells
    • Epub ahead of print
    • Teahan O, Bevan CL, Waxman J, Keun HC. Metabolic signatures of malignant progression in prostate epithelial cells. Int J Biochem Cell Biol 2010;Epub ahead of print
    • (2010) Int J Biochem Cell Biol
    • Teahan, O.1    Bevan, C.L.2    Waxman, J.3    Keun, H.C.4
  • 32
    • 0030721735 scopus 로고    scopus 로고
    • In vivo quantification of citrate concentration and water T2 relaxation time of the pathologic prostate gland using 1H MRS and MRI
    • Liney GP, Turnbull LW, Lowry M, Turnbull LS, Knowles AJ, Horsman A. In vivo quantification of citrate concentration and water T2 relaxation time of the pathologic prostate gland using 1H MRS and MRI. Magn Reson Imaging 1997;15:1177-86.
    • (1997) Magn Reson Imaging , vol.15 , pp. 1177-1186
    • Liney, G.P.1    Turnbull, L.W.2    Lowry, M.3    Turnbull, L.S.4    Knowles, A.J.5    Horsman, A.6
  • 33
    • 12444279265 scopus 로고
    • On the origin of cancer cells
    • Warburg O. On the origin of cancer cells. Science 1956;123:309-14.
    • (1956) Science , vol.123 , pp. 309-314
    • Warburg, O.1
  • 35
    • 77950567318 scopus 로고    scopus 로고
    • Magnetic resonance spectroscopic imaging (1H-MRSI) and dynamic contrast-enhanced magnetic resonance (DCE-MRI): Pattern changes from inflammation to prostate cancer
    • Sciarra A, Panebianco V, Ciccariello M, Salciccia S, Lisi D, Osimani M, et al. Magnetic resonance spectroscopic imaging (1H-MRSI) and dynamic contrast-enhanced magnetic resonance (DCE-MRI): pattern changes from inflammation to prostate cancer. Cancer Invest 2010;28:424-32.
    • (2010) Cancer Invest , vol.28 , pp. 424-432
    • Sciarra, A.1    Panebianco, V.2    Ciccariello, M.3    Salciccia, S.4    Lisi, D.5    Osimani, M.6
  • 36
    • 51649097613 scopus 로고    scopus 로고
    • Dynamic contrast-enhanced MRI and MR diffusion imaging to distinguish between glandular and stromal prostatic tissues
    • Noworolski SM, Vigneron DB, Chen AP, Kurhanewicz J. Dynamic contrast-enhanced MRI and MR diffusion imaging to distinguish between glandular and stromal prostatic tissues. Magn Reson Imaging 2008;26:1071-80.
    • (2008) Magn Reson Imaging , vol.26 , pp. 1071-1080
    • Noworolski, S.M.1    Vigneron, D.B.2    Chen, A.P.3    Kurhanewicz, J.4
  • 37
    • 17144387912 scopus 로고    scopus 로고
    • Metabolic characterization of human prostate cancer with tissue magnetic resonance spectroscopy
    • Cheng LL, Burns MA, Taylor JL, He W, Halpern EF, McDougal WS, et al. Metabolic characterization of human prostate cancer with tissue magnetic resonance spectroscopy. Cancer Res 2005;65:3030-4. (Pubitemid 40524579)
    • (2005) Cancer Research , vol.65 , Issue.8 , pp. 3030-3034
    • Cheng, L.L.1    Burns, M.A.2    Taylor, J.L.3    He, W.4    Halpern, E.F.5    McDougal, W.S.6    Wu, C.-L.7
  • 38
    • 72949087995 scopus 로고    scopus 로고
    • Use of the 1-mm micro-probe for metabolic analysis on small volume biological samples
    • Serkova NJ, Freund AS, Brown JL, Kominsky DJ. Use of the 1-mm micro-probe for metabolic analysis on small volume biological samples. J Cell Mol Med 2009;13:1933-41.
    • (2009) J Cell Mol Med , vol.13 , pp. 1933-1941
    • Serkova, N.J.1    Freund, A.S.2    Brown, J.L.3    Kominsky, D.J.4
  • 39
    • 0033557163 scopus 로고    scopus 로고
    • Citrate in the diagnosis of prostate cancer
    • DOI 10.1002/(SICI)1097-0045(19990215)38:3<237::AID-PROS8>3.0.CO;2-O
    • Costello LC, Franklin RB, Narayan P. Citrate in the diagnosis of prostate cancer. Prostate 1999;38:237-45. (Pubitemid 29054940)
    • (1999) Prostate , vol.38 , Issue.3 , pp. 237-245
    • Costello, L.C.1    Franklin, R.B.2    Narayan, P.3
  • 40
    • 33750435528 scopus 로고    scopus 로고
    • Therapeutic targets and biomarkers identified in cancer choline phospholipid metabolism
    • DOI 10.2217/14622416.7.7.1109
    • Glunde K, Serkova NJ. Therapeutic targets and biomarkers identified in cancer choline phospholipid metabolism. Pharmacogenomics 2006;7:1109-23. (Pubitemid 44644788)
    • (2006) Pharmacogenomics , vol.7 , Issue.7 , pp. 1109-1123
    • Glunde, K.1    Serkova, N.J.2
  • 41
    • 0030952929 scopus 로고    scopus 로고
    • Proton MRS of human prostatic fluid: Correlations between citrate, spermine, and myo-inositol levels and changes with disease
    • DOI 10.1002/(SICI)1097-0045(19970301)30:4<248::AID-PROS4>3.0.CO;2-H
    • Lynch MJ, Nicholson JK. Proton MRS of human prostatic fluid: correlations between citrate, spermine, and myo-inositol levels and changes with disease. Prostate 1997;30:248-55. (Pubitemid 27172836)
    • (1997) Prostate , vol.30 , Issue.4 , pp. 248-255
    • Lynch, M.J.1    Nicholson, J.K.2
  • 42
    • 0006961920 scopus 로고
    • The role of citric acid in the physiology of the prostate: A preliminary report
    • Cooper JF, Imfeld H. The role of citric acid in the physiology of the prostate: a preliminary report. J Urol 1959;81:157-64.
    • (1959) J Urol , vol.81 , pp. 157-164
    • Cooper, J.F.1    Imfeld, H.2
  • 43
    • 12544249171 scopus 로고    scopus 로고
    • A decrease in 1H nuclear magnetic resonance spectroscopically determined citrate in human seminal fluid accompanies the development of prostate adenocarcinoma
    • Averna TA, Kline EE, Smith AY, Sillerud LO. A decrease in 1H nuclear magnetic resonance spectroscopically determined citrate in human seminal fluid accompanies the development of prostate adenocarcinoma. J Urol 2005;173:433-8.
    • (2005) J Urol , vol.173 , pp. 433-438
    • Averna, T.A.1    Kline, E.E.2    Smith, A.Y.3    Sillerud, L.O.4
  • 44
    • 33750300129 scopus 로고    scopus 로고
    • 1H Nuclear Magnetic Resonance Spectroscopy Outperform Prostate Specific Antigen in Prostate Cancer Detection
    • DOI 10.1016/j.juro.2006.07.054, PII S0022534706016843
    • Kline EE, Treat EG, Averna TA, Davis MS, Smith AY, Sillerud LO. Citrate concentrations in human seminal fluid and expressed prostatic fluid determined via 1H nuclear magnetic resonance spectroscopy outperform prostate specific antigen in prostate cancer detection. J Urol 2006;176:2274-9. (Pubitemid 44633142)
    • (2006) Journal of Urology , vol.176 , Issue.5 , pp. 2274-2279
    • Kline, E.E.1    Treat, E.G.2    Averna, T.A.3    Davis, M.S.4    Smith, A.Y.5    Sillerud, L.O.6
  • 45
    • 0030483188 scopus 로고    scopus 로고
    • Zinc concentration in human prostatic fluid: Normal, chronic prostatitis, adenoma and cancer
    • DOI 10.1007/BF02552165
    • Zaichick VY, Sviridova TV, Zaichick SV. Zinc concentration in human prostatic fluid: normal, chronic prostatitis, adenoma and cancer. Int Urol Nephrol 1996;28:687-94. (Pubitemid 27110256)
    • (1996) International Urology and Nephrology , vol.28 , Issue.5 , pp. 687-694
    • Zaichick, V.Y.1    Sviridova, T.V.2    Zaichick, S.V.3
  • 46
    • 84965090724 scopus 로고
    • The role of citric acid in the physiology of the prostate. 3. lactate/citrate ratios in benign and malignant prostatic homogenates as an index of prostatic malignancy
    • Cooper JF, Farid I. The role of citric acid in the physiology of the prostate. 3. lactate/citrate ratios in benign and malignant prostatic homogenates as an index of prostatic malignancy. J Urol 1964;92:533-6.
    • (1964) J Urol , vol.92 , pp. 533-536
    • Cooper, J.F.1    Farid, I.2
  • 49
    • 56149099975 scopus 로고    scopus 로고
    • Comparison of radiolabeled choline and ethanolamine as probe for cancer detection
    • Mintz A, Wang L, Ponde DE. Comparison of radiolabeled choline and ethanolamine as probe for cancer detection. Cancer Biol Ther 2008;7:742-7.
    • (2008) Cancer Biol Ther , vol.7 , pp. 742-747
    • Mintz, A.1    Wang, L.2    Ponde, D.E.3
  • 50
    • 0033371680 scopus 로고    scopus 로고
    • Tumour phospholipid metabolism
    • DOI 10.1002/(SICI)1099-1492(199911)12:7<413::AID-NBM587>3.0.CO;2-U
    • Podo F. Tumour phospholipid metabolism. NMR Biomed 1999; 12:413-39. (Pubitemid 30016999)
    • (1999) NMR in Biomedicine , vol.12 , Issue.7 , pp. 413-439
    • Podo, F.1
  • 51
    • 57449113368 scopus 로고    scopus 로고
    • High resolution magic angle spinning NMR spectroscopy for metabolic assessment of cancer presence and Gleason score in human prostate needle biopsies
    • van Asten JJ, Cuijpers V, Hulsbergen-van de Kaa C, Soede-Huijbregts C, Witjes JA, Verhofstad A, et al. High resolution magic angle spinning NMR spectroscopy for metabolic assessment of cancer presence and Gleason score in human prostate needle biopsies. MAGMA 2008;21:435-42.
    • (2008) MAGMA , vol.21 , pp. 435-442
    • Van Asten, J.J.1    Cuijpers, V.2    Hulsbergen-Van De Kaa, C.3    Soede-Huijbregts, C.4    Witjes, J.A.5    Verhofstad, A.6
  • 52
    • 51449121886 scopus 로고    scopus 로고
    • Evaluation of lactate and alanine as metabolic biomarkers of prostate cancer using 1H HR-MAS spectroscopy of biopsy tissues
    • Tessem MB, Swanson MG, Keshari KR, Albers MJ, Joun D, Tabatabai ZL, et al. Evaluation of lactate and alanine as metabolic biomarkers of prostate cancer using 1H HR-MAS spectroscopy of biopsy tissues. Magn Reson Med 2008;60:510-6.
    • (2008) Magn Reson Med , vol.60 , pp. 510-516
    • Tessem, M.B.1    Swanson, M.G.2    Keshari, K.R.3    Albers, M.J.4    Joun, D.5    Tabatabai, Z.L.6
  • 53
    • 77958449506 scopus 로고    scopus 로고
    • The relationship between proangiogenic gene expression levels in prostate cancer and their prognostic value for clinical outcomes
    • Mori R, Dorff TB, Xiong S, Tarabolous CJ, Ye W, Groshen S, et al. The relationship between proangiogenic gene expression levels in prostate cancer and their prognostic value for clinical outcomes. Prostate 2010;70:1692-700.
    • (2010) Prostate , vol.70 , pp. 1692-1700
    • Mori, R.1    Dorff, T.B.2    Xiong, S.3    Tarabolous, C.J.4    Ye, W.5    Groshen, S.6
  • 54
    • 76649086671 scopus 로고    scopus 로고
    • Detection of polyunsaturated omega-6 fatty acid in human malignant prostate tissue by 1D and 2D high-resolution magic angle spinning NMR spectroscopy
    • Stenman K, Hauksson JB, Gröbner G, Stattin P, Bergh A, Riklund K. Detection of polyunsaturated omega-6 fatty acid in human malignant prostate tissue by 1D and 2D high-resolution magic angle spinning NMR spectroscopy. MAGMA 2009;22: 327-31.
    • (2009) MAGMA , vol.22 , pp. 327-331
    • Stenman, K.1    Hauksson, J.B.2    Gröbner, G.3    Stattin, P.4    Bergh, A.5    Riklund, K.6
  • 56
    • 0034087595 scopus 로고    scopus 로고
    • Three-dimensional magnetic resonance spectroscopic imaging of brain and prostate cancer
    • Kurhanewicz J, Vigneron DB, Nelson SJ. Three-dimensional magnetic resonance spectroscopic imaging of brain and prostate cancer. Neoplasia 2000;2:166-89. (Pubitemid 30123187)
    • (2000) Neoplasia , vol.2 , Issue.1-2 , pp. 166-189
    • Kurhanewicz, J.1    Vigneron, D.B.2    Nelson, S.J.3
  • 59
    • 39549111032 scopus 로고    scopus 로고
    • Prostate cancer: Identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging--correlation with pathologic findings
    • Mazaheri Y, Shukla-Dave A, Hricak H, Fine SW, Zhang J, Inurrigarro G, et al. Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging--correlation with pathologic findings. Radiology 2008;246:480-8.
    • (2008) Radiology , vol.246 , pp. 480-488
    • Mazaheri, Y.1    Shukla-Dave, A.2    Hricak, H.3    Fine, S.W.4    Zhang, J.5    Inurrigarro, G.6
  • 63
    • 77951826127 scopus 로고    scopus 로고
    • Retrospective analysis of prostate cancer recurrence potential with tissue metabolomic profiles
    • Maxeiner A, Adkins CB, Zhang Y, Taupitz M, Halpern EF, McDougal WS, et al. Retrospective analysis of prostate cancer recurrence potential with tissue metabolomic profiles. Prostate 2010;70:710-7.
    • (2010) Prostate , vol.70 , pp. 710-717
    • Maxeiner, A.1    Adkins, C.B.2    Zhang, Y.3    Taupitz, M.4    Halpern, E.F.5    McDougal, W.S.6
  • 67
    • 46849085176 scopus 로고    scopus 로고
    • Imaging and cancer: A review
    • Fass L. Imaging and cancer: a review. Mol Oncol 2008;2:115-52.
    • (2008) Mol Oncol , vol.2 , pp. 115-152
    • Fass, L.1
  • 69
    • 33846444320 scopus 로고    scopus 로고
    • High-grade prostatic intraepithelial neoplasia in patients with prostate cancer: MR and MR spectroscopic imaging features - Initial experience
    • DOI 10.1148/radiol.2422051828
    • Hom JJ, Coakley FV, Simko JP, Lu Y, Qayyum A, Westphalen AC, et al. High-grade prostatic intraepithelial neoplasia in patients with prostate cancer: MR and MR spectroscopic imaging features-initial experience. Radiology 2007;242:483-9. (Pubitemid 46146201)
    • (2007) Radiology , vol.242 , Issue.2 , pp. 483-489
    • Hom, J.J.1    Coakley, F.V.2    Simko, J.P.3    Lu, Y.4    Qayyum, A.5    Westphalen, A.C.A.6    Schmitt, L.D.7    Carroll, P.R.8    Kurhanewicz, J.9
  • 70
    • 0017345616 scopus 로고
    • Deoxyribonucleic acid and polyamine synthesis in rat ventral prostrate. Effects of age of the intact rat and androgen stimulation of the castrated rat with testosterone, 5 alpha-dihydrotestosterone and 5 alpha-androstane-3 beta, 17 beta-diol
    • Takyi EE, Fuller DJ, Donaldson LJ, Thomas GH. Deoxyribonucleic acid and polyamine synthesis in rat ventral prostrate. Effects of age of the intact rat and androgen stimulation of the castrated rat with testosterone, 5 alpha-dihydrotestosterone and 5 alpha-androstane-3 beta, 17 beta-diol. Biochem J 1977; 162:87-97.
    • (1977) Biochem J , vol.162 , pp. 87-97
    • Takyi, E.E.1    Fuller, D.J.2    Donaldson, L.J.3    Thomas, G.H.4
  • 71
    • 0036794336 scopus 로고    scopus 로고
    • Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer
    • DOI 10.1002/jmri.10172
    • Kurhanewicz J, Swanson MG, Nelson SJ, Vigneron DB. Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer. J Magn Reson Imaging 2002;16:451-63. (Pubitemid 35167879)
    • (2002) Journal of Magnetic Resonance Imaging , vol.16 , Issue.4 , pp. 451-463
    • Kurhanewicz, J.1    Swanson, M.G.2    Nelson, S.J.3    Vigneron, D.B.4
  • 74
    • 0031865378 scopus 로고    scopus 로고
    • PET imaging of prostate cancer using carbon-11-choline
    • Hara T, Kosaka N, Kishi H. PET imaging of prostate cancer using carbon-11-choline. J Nucl Med 1998;39:990-5. (Pubitemid 28270113)
    • (1998) Journal of Nuclear Medicine , vol.39 , Issue.6 , pp. 990-995
    • Hara, T.1    Kosaka, N.2    Kishi, H.3
  • 76
    • 0036282024 scopus 로고    scopus 로고
    • 18F] fluorodeoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer
    • Price DT, Coleman RE, Liao RP, Robertson CN, Polascik TJ, DeGrado TR. Comparison of [18 F]fluorocholine and [18 F]fluorodeoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer. J Urol 2002;168:273-80. (Pubitemid 34640843)
    • (2002) Journal of Urology , vol.168 , Issue.1 , pp. 273-280
    • Price, D.T.1    Coleman, R.E.2    Liao, R.P.3    Robertson, C.N.4    Polascik, T.J.5    DeGrado, T.R.6
  • 77
    • 0024504488 scopus 로고
    • Quantitative measurements of regional glucose utilization and rate of valine incorporation into proteins by double-tracer autoradiography in the rat brain tumor model
    • Kirikae M, Diksic M, Yamamoto YL. Quantitative measurements of regional glucose utilization and rate of valine incorporation into proteins by double-tracer autoradiography in the rat brain tumor model. J Cereb Blood Flow Metab 1989;9:87-95. (Pubitemid 19053439)
    • (1989) Journal of Cerebral Blood Flow and Metabolism , vol.9 , Issue.1 , pp. 87-95
    • Kirikae, M.1    Diksic, M.2    Yamamoto, Y.L.3
  • 78
    • 0027519364 scopus 로고
    • A comparative study on protein incorporation of L-[methyl-3H]methio nine, L-[1-14C]leucine and L-2-[18F]fluorotyrosine in tumor bearing mice
    • Ishiwata K, Kubota K, Murakami M, Kubota R, Senda M. A comparative study on protein incorporation of L-[methyl-3H]methio nine, L-[1-14C]leucine and L-2-[18F]fluorotyrosine in tumor bearing mice. Nucl Med Biol 1993;20:895-9.
    • (1993) Nucl Med Biol , vol.20 , pp. 895-899
    • Ishiwata, K.1    Kubota, K.2    Murakami, M.3    Kubota, R.4    Senda, M.5
  • 79
    • 0017057288 scopus 로고
    • Physical and chemical determinations of prostatic secretion in benign hyperplasia, prostatitis, and adenocarcinoma
    • Anderson RU, Fair WR. Physical and chemical determinations of prostatic secretion in benign hyperplasia, prostatitis, and adenocarcinoma. Invest Urol 1976;14:137-40. (Pubitemid 8002347)
    • (1976) Investigative Urology , vol.14 , Issue.2 , pp. 137-140
    • Anderson, R.U.1    Fair, W.R.2
  • 81
    • 0345189502 scopus 로고    scopus 로고
    • In vivo proton magnetic resonance spectroscopy of diseased prostate: Spectroscopic features of malignant versus benign pathology
    • García-Segura JM, Sánchez-Chapado M, Ibarburen C, Viaño J, Angulo JC, González J, et al. In vivo proton magnetic resonance spectroscopy of diseased prostate: spectroscopic features of malignant versus benign pathology. Magn Reson Imaging 1999;17: 755-65.
    • (1999) Magn Reson Imaging , vol.17 , pp. 755-765
    • García-Segura, J.M.1    Sánchez-Chapado, M.2    Ibarburen, C.3    Viaño, J.4    Angulo, J.C.5    González, J.6
  • 83
    • 77952880618 scopus 로고    scopus 로고
    • Is urinary sarcosine useful to identify patients with significant prostate cancer? The trials and tribulations of biomarker development
    • Schalken JA. Is urinary sarcosine useful to identify patients with significant prostate cancer? The trials and tribulations of biomarker development. Eur Urol 2010;58:19-20.
    • (2010) Eur Urol , vol.58 , pp. 19-20
    • Schalken, J.A.1
  • 84
    • 77952883657 scopus 로고    scopus 로고
    • Reply from Authors re: Jack A. Schalken. Is urinary sarcosine useful to identify patients with significant prostate cancer? The trials and tribulations of biomarker development. Eur Urol 2010;58:19-20
    • Stephan C, Jentzmik F, Jung K. Reply from Authors re: Jack A. Schalken. Is urinary sarcosine useful to identify patients with significant prostate cancer? The trials and tribulations of biomarker development. Eur Urol 2010;58:19-20. Eur Urol 2010;58:20-1
    • (2010) Eur Urol , vol.58 , pp. 20-21
    • Stephan, C.1    Jentzmik, F.2    Jung, K.3
  • 85
    • 77955512062 scopus 로고    scopus 로고
    • Re: Florian Jentzmik, Carsten Stephan, Kurt Miller, et al. Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours. Eur Urol 2010;58:12-8
    • Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, et al. Re: Florian Jentzmik, Carsten Stephan, Kurt Miller, et al. Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours. Eur Urol 2010;58:12-8. Eur Urol 2010;58:e29-30.
    • (2010) Eur Urol , vol.58
    • Sreekumar, A.1    Poisson, L.M.2    Rajendiran, T.M.3    Khan, A.P.4    Cao, Q.5    Yu, J.6
  • 86
    • 77955517340 scopus 로고    scopus 로고
    • Reply to Arun Sreekumar, Laila M. Poisson, Thekkelnaycke M. Rajendiran, et al.'s Letter to the Editor re: Florian Jentzmik, Carsten Stephan, Kurt Miller, et al. Sarcosine in Urine after Digital Rectal Examination Fails as a Marker in Prostate Cancer Detection and Identification of Aggressive Tumours. Eur Urol 2010;58:12-8
    • Jentzmik F, Stephan C, Jung K. Reply to Arun Sreekumar, Laila M. Poisson, Thekkelnaycke M. Rajendiran, et al.'s Letter to the Editor re: Florian Jentzmik, Carsten Stephan, Kurt Miller, et al. Sarcosine in Urine after Digital Rectal Examination Fails as a Marker in Prostate Cancer Detection and Identification of Aggressive Tumours. Eur Urol 2010;58:12-8. Eur Urol 2010;58: e31-2
    • (2010) Eur Urol , vol.58
    • Jentzmik, F.1    Stephan, C.2    Jung, K.3
  • 87
    • 77956555276 scopus 로고    scopus 로고
    • Re: Florian Jentzmik, Carsten Stephan, Kurt Miller, et al. Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours. Eur Urol 2010;58:12-8
    • Hewavitharana AK. Re: Florian Jentzmik, Carsten Stephan, Kurt Miller, et al. Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours. Eur Urol 2010;58:12-8. Eur Urol 2010;58:e39-40.
    • (2010) Eur Urol , vol.58
    • Hewavitharana, A.K.1
  • 88
    • 79952497664 scopus 로고    scopus 로고
    • Reply to Amitha K Hewavitharana's Letter to the Editor re: Florian Jentzmik, Carsten Stephan, Kurt Miller, et al. Sarcosine in Urine After Digital Examination Fails as a Marker in Prostate Cancer Detection and Identification of Aggressive Tumours. Eur Urol 2010;58:12-8
    • Jentzmik F, Stephan C, Jung K. Reply to Amitha K Hewavitharana's Letter to the Editor re: Florian Jentzmik, Carsten Stephan, Kurt Miller, et al. Sarcosine in Urine After Digital Examination Fails as a Marker in Prostate Cancer Detection and Identification of Aggressive Tumours. Eur Urol 2010;58:12-8. Eur Urol 2010;58: e41-2.
    • (2010) Eur Urol , vol.58
    • Jentzmik, F.1    Stephan, C.2    Jung, K.3
  • 89
    • 77957573787 scopus 로고    scopus 로고
    • Re: Florian Jentzmik, Carsten Stephan, Kurt Miller, et al. Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours. Eur Urol 2010; 58:12-8
    • Colleselli D, Stenzl A, Schwentner C. Re: Florian Jentzmik, Carsten Stephan, Kurt Miller, et al. Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours. Eur Urol 2010; 58:12-8. Eur Urol 2010.
    • (2010) Eur Urol
    • Colleselli, D.1    Stenzl, A.2    Schwentner, C.3
  • 90
    • 77952880168 scopus 로고    scopus 로고
    • Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours
    • Jentzmik F, Stephan C, Miller K, Schrader M, Erbersdobler A, Kristiansen G, et al. Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours. Eur Urol 2010;58:12-8.
    • (2010) Eur Urol , vol.58 , pp. 12-18
    • Jentzmik, F.1    Stephan, C.2    Miller, K.3    Schrader, M.4    Erbersdobler, A.5    Kristiansen, G.6
  • 91
    • 78651318867 scopus 로고    scopus 로고
    • Sarcosine in prostate cancer tissue is not a differential metabolite for prostate cancer aggressiveness and biochemical progression
    • Jentzmik F, Stephan C, Lein M, Miller K, Kamlage B, Bethan B, et al. Sarcosine in prostate cancer tissue is not a differential metabolite for prostate cancer aggressiveness and biochemical progression. J Urol 2011;185:706-11.
    • (2011) J Urol , vol.185 , pp. 706-711
    • Jentzmik, F.1    Stephan, C.2    Lein, M.3    Miller, K.4    Kamlage, B.5    Bethan, B.6
  • 93
    • 61649091570 scopus 로고    scopus 로고
    • Acid ceramidase upregulation in prostate cancer cells confers resistance to radiation: AC inhibition, a potential radio-sensitizer
    • Mahdy AE, Cheng JC, Li J, Elojeimy S, Meacham WD, Turner LS, et al. Acid ceramidase upregulation in prostate cancer cells confers resistance to radiation: AC inhibition, a potential radio-sensitizer. Mol Ther 2009;17:430-8.
    • (2009) Mol Ther , vol.17 , pp. 430-438
    • Mahdy, A.E.1    Cheng, J.C.2    Li, J.3    Elojeimy, S.4    Meacham, W.D.5    Turner, L.S.6
  • 94
    • 58849115858 scopus 로고    scopus 로고
    • Combined magnetic resonance imaging and magnetic resonance spectroscopy imaging in the diagnosis of prostate cancer: A systematic review and meta-analysis
    • Umbehr M, Bachmann LM, Held U, Kessler TM, Sulser T, Weishaupt D, et al. Combined magnetic resonance imaging and magnetic resonance spectroscopy imaging in the diagnosis of prostate cancer: a systematic review and meta-analysis. Eur Urol 2009;55:575-90.
    • (2009) Eur Urol , vol.55 , pp. 575-590
    • Umbehr, M.1    Bachmann, L.M.2    Held, U.3    Kessler, T.M.4    Sulser, T.5    Weishaupt, D.6
  • 95
    • 0035815463 scopus 로고    scopus 로고
    • 1H NMR spectroscopy at 9.4 T
    • DOI 10.1016/S0014-5793(01)02329-8, PII S0014579301023298
    • Cheng LL, Wu C, Smith MR, Gonzalez RG. Non-destructive quantitation of spermine in human prostate tissue samples using HRMAS 1H NMR spectroscopy at 9.4 T. FEBS Lett 2001; 494:112-6. (Pubitemid 32289382)
    • (2001) FEBS Letters , vol.494 , Issue.1-2 , pp. 112-116
    • Cheng, L.L.1    Wu, C.-L.2    Smith, M.R.3    Gonzalez, R.G.4
  • 96
    • 67649354645 scopus 로고    scopus 로고
    • Molecular imaging of prostate cancer: A concise synopsis
    • Jadvar H. Molecular imaging of prostate cancer: a concise synopsis. Mol Imaging 2009;8:56-64.
    • (2009) Mol Imaging , vol.8 , pp. 56-64
    • Jadvar, H.1
  • 97
    • 0028822816 scopus 로고
    • Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: Detection via localized proton spectroscopy
    • Kurhanewicz J, Vigneron DB, Nelson SJ, Hricak H, MacDonald JM, Konety B, et al. Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy. Urology 1995;45:459-66.
    • (1995) Urology , vol.45 , pp. 459-466
    • Kurhanewicz, J.1    Vigneron, D.B.2    Nelson, S.J.3    Hricak, H.4    MacDonald, J.M.5    Konety, B.6
  • 99
    • 52949125968 scopus 로고    scopus 로고
    • Potential of magnetic resonance spectroscopic imaging in predicting absence of prostate cancer in men with serum prostate- Specific antigen between 4 and 10 ng/ml: A follow-up study
    • Kumar R, Nayyar R, Kumar V, Gupta NP, Hemal AK, Jagannathan NR, et al. Potential of magnetic resonance spectroscopic imaging in predicting absence of prostate cancer in men with serum prostate- specific antigen between 4 and 10 ng/ml: a follow-up study. Urology 2008;72:859-63.
    • (2008) Urology , vol.72 , pp. 859-863
    • Kumar, R.1    Nayyar, R.2    Kumar, V.3    Gupta, N.P.4    Hemal, A.K.5    Jagannathan, N.R.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.